Penile blood pressure is useful to identify candidates for tadalafil treatment in patients with lower urinary tract symptoms.


Journal

BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 20 6 2018
medline: 21 8 2019
entrez: 20 6 2018
Statut: ppublish

Résumé

To determine whether penile blood pressure (PBP) can be used to identify patients who can benefit from tadalafil treatment, the correlation between PBP at baseline and changes in lower urinary tract symptoms (LUTS) induced by tadalafil treatment was studied prospectively. Patients with BPH who were poor responders to α In all, 51 patients were investigated. The IPSS in the low-PBP group decreased immediately after the start of treatment, and there was significant improvement in the IPSS from baseline at 4 and 12 weeks after the start of treatment, whilst the IPSS in the high-PBP group did not show significant changes. On multivariate analysis, PBP at baseline, anticholinergic drug use, and IPSS at baseline were significant predictors of a good IPSS response to tadalafil treatment. This study demonstrated that PBP could reliably identify patients with BPH who could benefit from tadalafil treatment. Patients with low PBP could be better responders to tadalafil.

Identifiants

pubmed: 29917304
doi: 10.1111/bju.14456
doi:

Substances chimiques

Adrenergic alpha-1 Receptor Antagonists 0
Cholinergic Antagonists 0
Phosphodiesterase 5 Inhibitors 0
Tadalafil 742SXX0ICT

Types de publication

Journal Article

Langues

eng

Pagination

124-129

Informations de copyright

© 2018 The Authors BJU International © 2018 BJU International Published by John Wiley & Sons Ltd.

Auteurs

Juntaro Koyama (J)

Shirakawa Kousei General Hospital, Shirakawa, Japan.

Yasuhiro Kaiho (Y)

Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Yoshihide Kawasaki (Y)

Tohoku University Graduate School of Medicine, Sendai, Japan.

Tomonori Sato (T)

Shirakawa Kousei General Hospital, Shirakawa, Japan.

Taro Fukushi (T)

Shirakawa Kousei General Hospital, Shirakawa, Japan.

Atsushi Kyan (A)

Shirakawa Kousei General Hospital, Shirakawa, Japan.

Yoichi Arai (Y)

Tohoku University Graduate School of Medicine, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH